DK29491A - O-glycosyleret igf-1 - Google Patents

O-glycosyleret igf-1 Download PDF

Info

Publication number
DK29491A
DK29491A DK029491A DK29491A DK29491A DK 29491 A DK29491 A DK 29491A DK 029491 A DK029491 A DK 029491A DK 29491 A DK29491 A DK 29491A DK 29491 A DK29491 A DK 29491A
Authority
DK
Denmark
Prior art keywords
igf
glycosylated
glycosylated igf
expressed
obtaining
Prior art date
Application number
DK029491A
Other languages
English (en)
Other versions
DK175360B1 (da
DK29491D0 (da
Inventor
Anna Skottner-Lundin
Linda Fryklund
Paer Gellerfors
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of DK29491D0 publication Critical patent/DK29491D0/da
Publication of DK29491A publication Critical patent/DK29491A/da
Application granted granted Critical
Publication of DK175360B1 publication Critical patent/DK175360B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100294A 1988-08-20 1991-02-20 O-glycosyleret IGF-1 og farmaceutisk sammensætning indeholdende O-glycosyleret IGF-1 samt fremgangsmåder til fremstilling af begge DK175360B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888819826A GB8819826D0 (en) 1988-08-20 1988-08-20 Glycosylated igf-1
GB8819826 1988-08-20
PCT/EP1989/000972 WO1990002198A1 (en) 1988-08-20 1989-08-17 O-glycosylated igf-1
EP8900972 1989-08-17

Publications (3)

Publication Number Publication Date
DK29491D0 DK29491D0 (da) 1991-02-20
DK29491A true DK29491A (da) 1991-04-19
DK175360B1 DK175360B1 (da) 2004-09-13

Family

ID=10642464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100294A DK175360B1 (da) 1988-08-20 1991-02-20 O-glycosyleret IGF-1 og farmaceutisk sammensætning indeholdende O-glycosyleret IGF-1 samt fremgangsmåder til fremstilling af begge

Country Status (15)

Country Link
US (1) US5273966A (da)
EP (2) EP0360411B1 (da)
JP (1) JP2543998B2 (da)
AT (1) ATE109206T1 (da)
AU (1) AU623675B2 (da)
CA (1) CA1335802C (da)
DE (1) DE68917061T2 (da)
DK (1) DK175360B1 (da)
ES (1) ES2060778T3 (da)
FI (1) FI102282B (da)
GB (1) GB8819826D0 (da)
IE (1) IE65096B1 (da)
NO (1) NO180636C (da)
NZ (1) NZ230383A (da)
WO (1) WO1990002198A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
ATE220105T1 (de) * 1991-04-01 2002-07-15 Merck & Co Inc Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
ATE148710T1 (de) * 1992-12-02 1997-02-15 Hoechst Ag Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101459789B1 (ko) * 2006-06-09 2014-11-07 노파르티스 아게 안정화된 인슐린-유사 성장 인자 폴리펩티드
EP2494050A4 (en) * 2009-10-30 2013-10-30 Merck Sharp & Dohme GRANULOCYTIC COLONY STIMULATING FACTOR MADE IN GLYCOENGINEERED PICHIA PASTORIS
US20100172865A1 (en) * 2010-03-18 2010-07-08 Shantha Totada R Methods of enhancing hair growth
EP2571992B1 (en) 2010-05-21 2018-04-25 Merrimack Pharmaceuticals, Inc. Bi-specific fusion proteins
US20160271265A1 (en) 2013-10-02 2016-09-22 Novartis Ag Insulin-like growth factor mimetics for use in therapy
CN108367048B (zh) 2015-10-02 2022-08-12 银溪制药股份有限公司 用于组织修复的双特异性治疗性蛋白质

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207842A (en) * 1983-04-25 1988-02-12 Chiron Corp Production of human insulin-like growth factor (igf) using cdna

Also Published As

Publication number Publication date
JPH05505514A (ja) 1993-08-19
IE892652L (en) 1990-02-20
EP0360411B1 (en) 1994-07-27
NZ230383A (en) 1992-01-29
FI910795A0 (fi) 1991-02-19
AU623675B2 (en) 1992-05-21
AU4051889A (en) 1990-03-23
FI102282B1 (fi) 1998-11-13
CA1335802C (en) 1995-06-06
NO180636B (no) 1997-02-10
NO910669L (no) 1991-02-19
DK175360B1 (da) 2004-09-13
NO180636C (no) 1997-05-21
FI102282B (fi) 1998-11-13
DK29491D0 (da) 1991-02-20
JP2543998B2 (ja) 1996-10-16
GB8819826D0 (en) 1988-09-21
IE65096B1 (en) 1995-10-04
EP0360411A1 (en) 1990-03-28
NO910669D0 (no) 1991-02-19
ATE109206T1 (de) 1994-08-15
DE68917061D1 (de) 1994-09-01
EP0429502A1 (en) 1991-06-05
DE68917061T2 (de) 1994-11-17
ES2060778T3 (es) 1994-12-01
US5273966A (en) 1993-12-28
WO1990002198A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
DK0402300T3 (da) Fremstilling i bakterier af gær og hæmoglobin og analoger dertil
ATE107513T1 (de) Stabilisierte formulierungen mit hydrohoben proteinen.
DE68922602D1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
ATE109206T1 (de) O-glycosylierter igf-1.
AU7184487A (en) Human g-csf protein expression
DE68929551D1 (de) Menschliche DNase
IT8520242A0 (it) Polipeptide umano fisiologicamente attivo.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DE68926859D1 (de) Natürlicher killerzellen-stimulationsfaktor
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
DE3788004D1 (de) Verwendung von Tetrahydrocortisol in der Therapie von Glaukom.
FI880453A7 (fi) Nukutusainekoostumus ja menetelmä sen käyttämiseksi.
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
DE69518152D1 (de) Flüssige beta-interferon formulierungen
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
FI893587L (fi) Menetelmä ei-glykosyloidun rekombinantti-humaani-IL2:n valmistamiseksi sen pelkistyneessä muodossa
FI901039A7 (fi) Tuoli
FI920058A7 (fi) Menetelmä hirudiinien ja hirudiinin kaltaisten polypeptidien tuottamis eksi rekombinanttitekniikalla
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
AU3327789A (en) Expression of the hiv 24 kda 24 gag protein in methylotrophic yeast
FI891695A7 (fi) Lohen kasvuhormoonin ilmentäminen sukuun Pichia kuuluvassa metylotroofisessa hiivassa
SE8802685D0 (sv) Stol
ATE98217T1 (de) Terpen-amino-alkohole und deren medizinische verwendung.
IE891349L (en) EXPRESSION OF THE HIV kDa GAG PROTEIN IN YEAST

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK